Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
p63 promotes cell survival through fatty acid synthase.
Sabbisetti V, Di Napoli A, Seeley A, Amato AM, O'Regan E, Ghebremichael M, Loda M, Signoretti S. Sabbisetti V, et al. Among authors: amato am. PLoS One. 2009 Jun 11;4(6):e5877. doi: 10.1371/journal.pone.0005877. PLoS One. 2009. PMID: 19517019 Free PMC article.
Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy.
Choueiri TK, Regan MM, Rosenberg JE, Oh WK, Clement J, Amato AM, McDermott D, Cho DC, Atkins MB, Signoretti S. Choueiri TK, et al. Among authors: amato am. BJU Int. 2010 Sep;106(6):772-8. doi: 10.1111/j.1464-410X.2010.09218.x. Epub 2010 Mar 2. BJU Int. 2010. PMID: 20230385
The Male Reproductive System and Endocrine Disruptors.
Schiesaro MG, Amato AML, Maneschi C, Sciabica V, Pigatto E, Sanna M. Schiesaro MG, et al. Among authors: amato aml. Endocr Metab Immune Disord Drug Targets. 2022 Aug 15;22(7):686-703. doi: 10.2174/1871530321666211004100633. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 34607552
Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance.
Boscari F, Vettoretti M, Cavallin F, Amato AML, Uliana A, Vallone V, Avogaro A, Facchinetti A, Bruttomesso D. Boscari F, et al. Among authors: amato aml. J Endocrinol Invest. 2022 Jan;45(1):115-124. doi: 10.1007/s40618-021-01624-2. Epub 2021 Jul 1. J Endocrinol Invest. 2022. PMID: 34196924 Free PMC article. Clinical Trial.
Comparing the accuracy of transcutaneous sensor and 90-day implantable glucose sensor.
Boscari F, Vettoretti M, Amato AML, Vallone V, Uliana A, Iori E, Avogaro A, Facchinetti A, Bruttomesso D. Boscari F, et al. Among authors: amato aml. Nutr Metab Cardiovasc Dis. 2021 Feb 8;31(2):650-657. doi: 10.1016/j.numecd.2020.09.006. Epub 2020 Sep 12. Nutr Metab Cardiovasc Dis. 2021. PMID: 33594987 Clinical Trial.
Performance of the Steno type 1 risk engine for cardiovascular disease prediction in Italian patients with type 1 diabetes.
Boscari F, Morieri ML, Amato AML, Vallone V, Uliana A, Baritussio A, Vitturi N, Cipponeri E, Cavallin F, Avogaro A, Fadini GP, Bruttomesso D. Boscari F, et al. Among authors: amato aml. Nutr Metab Cardiovasc Dis. 2020 Sep 24;30(10):1813-1819. doi: 10.1016/j.numecd.2020.07.006. Epub 2020 Jul 11. Nutr Metab Cardiovasc Dis. 2020. PMID: 32807633
19 results